TULEBRAZ Trademark

Trademark Overview

On Friday, March 16, 2012, a trademark application was filed for TULEBRAZ with the United States Patent and Trademark Office. The USPTO has given the TULEBRAZ trademark a serial number of 85571355. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 2, 2015. This trademark is owned by Glaxo Group Limited. The TULEBRAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
tulebraz

General Information

Serial Number85571355
Word MarkTULEBRAZ
Filing DateFriday, March 16, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 2, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 7, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "TULEBRAZ" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 26, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, November 2, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 2, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2015EXTENSION 5 GRANTED
Friday, March 27, 2015EXTENSION 5 FILED
Friday, March 27, 2015TEAS EXTENSION RECEIVED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014EXTENSION 4 GRANTED
Tuesday, September 30, 2014EXTENSION 4 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 7, 2014EXTENSION 3 GRANTED
Monday, March 31, 2014EXTENSION 3 FILED
Monday, March 31, 2014TEAS EXTENSION RECEIVED
Tuesday, October 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2013EXTENSION 2 GRANTED
Wednesday, September 18, 2013EXTENSION 2 FILED
Wednesday, October 23, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 18, 2013TEAS EXTENSION RECEIVED
Friday, March 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 27, 2013EXTENSION 1 GRANTED
Wednesday, March 27, 2013EXTENSION 1 FILED
Wednesday, March 27, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 2, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 7, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 7, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 2, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 27, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 27, 2012DATA MODIFICATION COMPLETED
Wednesday, June 27, 2012DATA MODIFICATION COMPLETED
Monday, June 25, 2012ASSIGNED TO LIE
Saturday, June 23, 2012ASSIGNED TO EXAMINER
Monday, March 26, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 20, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

tulebraz pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological